Skip to content
Recall Observatory FDA recall evidence

Drug product

Mesalamine Delayed-Release Tablets, USP, 1.2 gram, 120-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 0591-2245-22.

D-0862-2020

February 20, 2020

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 85017
Status
Terminated
Classification
Class II
Quantity
3,695 bottles
Official record key
drug-enforcement:D-0862-2020

Official wording

Reason: Failed Dissolution Specifications: Low out of specification dissolution result observed during stability testing.

Code information: Lot #: 1342500A, Exp 10/2020

Distribution pattern: Nationwide in the USA.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification